The revised notice, issued on 10 July 2026, extends an Aptamil First Infant Formula recall that was first issued on 23 January 2026. It lists Aptamil 1 First Infant Milk in 700g packs with best-before dates from 22 August 2026 through 26 November 2026. Cow & Gate 1 First Infant Milk is also included in the updated notice.

For households with formula at home, the practical issue is whether a particular container matches the recall details. Consumers should check three identifiers against the Food Standards Agency notice: the product name, the pack size and the best-before date.

What consumers should check

The Aptamil listing is specific to Aptamil 1 First Infant Milk in a 700g pack. The affected best-before dates listed in the update begin on 22 August 2026 and end on 26 November 2026. A container should therefore be compared with the full listing rather than assessed only by its brand name.

The same principle applies to Cow & Gate. The updated notice names Cow & Gate 1 First Infant Milk, but consumers should use the product and date information in the notice to determine whether an individual container is covered.

Anyone who finds a matching product should stop using it and follow the instructions in the recall notice. Checking the packaging before preparing formula is especially important for parents, caregivers and other people responsible for feeding infants.

The action is a product-safety recall, not a general withdrawal of every Aptamil or Cow & Gate product. The presence of either brand name alone does not establish that a product is affected. The relevant combination is the listed product, the specified pack size where given and the applicable best-before information.

Why the update matters

Infant formula can be stored in homes and other places where babies are fed, meaning a change to a recall notice may require consumers to recheck products they previously considered safe to use. Extending the listed dates broadens the range of packaging that households need to examine.

The update also shows why recall notices rely on precise product identifiers. Aptamil products may be sold in multiple formats, and the notice does not describe the action as applying to the entire brand. For the Aptamil item named in the update, the 700g pack size and the best-before date range are central to identifying a potentially affected container.

The notice also distinguishes the Cow & Gate product from the Aptamil listing. Consumers with both brands should check each container separately rather than assuming that the same product or date details apply to both.

The Food Standards Agency notice does not state how many units were distributed or report confirmed illnesses connected to the products. It identifies the recall, the products covered and the packaging details consumers need in order to compare their supplies with the official notice.

Where to check the recall

The Food Standards Agency’s updated recall notice is the primary reference for the affected Aptamil and Cow & Gate products. The UK government’s product-safety database also provides a route for checking consumer recalls and related corrective actions.

The action described applies to products distributed in the United Kingdom. Consumers should follow the UK notice and its instructions instead of assuming that every product sold under either brand, in the UK or elsewhere, is affected. The immediate next step for households is to inspect relevant containers before use and compare them with the updated product, pack-size and best-before information.

The company reported net profit of CHF 3.5 billion and basic earnings per share of CHF 1.35. Organic growth in its Food and Snacks business was 3.7%, while retail sales grew organically by 3.6% and out-of-home sales grew by 4.1%.

The results show the continuing consumer and business consequences of a product-safety event for a multinational company whose brands are sold through global retail and out-of-home channels. Nestlé said the recall’s effect on demand persisted into the first half of the year, but it did not disclose a separate figure for how much revenue or profit the recall reduced.

Growth continued across major businesses

Nestlé said organic growth was supported by brands including Maggi, KitKat and Milo. “Organic growth” measures sales performance after excluding the effects of currency movements, acquisitions and disposals, according to the company’s reporting language in the results release.

The company’s reported figures also distinguish between where products are sold. Retail organic growth was 3.6%, while out-of-home organic growth was 4.1%. The out-of-home channel includes sales connected to consumption outside the home, while retail covers consumer purchases through stores and other retail channels.

Nestlé said structural cost savings were offset by increased investment and commercial spending. That means the savings did not translate directly into a stronger bottom line during the period because the company also spent more on commercial activity and brand-building.

The results therefore present a mixed picture: Nestlé reported positive growth and substantial profit, while also acknowledging that demand remained affected by the recall and that additional investment absorbed some of the benefit from cost savings.

Recall began in January

The infant-formula recall was not newly announced with the July results. In an April 23 sales update, Nestlé said it had launched a global precautionary recall of infant-formula batches in January 2026 after detecting cereulide.

Nestlé linked the contamination to an ingredient sourced from a global industry supplier. The company described the ingredient chain as international, and the recall as global. The available source material does not establish whether every affected product or market had fully returned to normal by July.

Cereulide is identified in the approved company material as the substance detected in connection with the recall. The packet does not provide additional findings about health outcomes, the number of recalled batches, the countries involved, or the volume of products removed. Those details are not included here because Nestlé’s results materials, as supplied, do not support them.

What the results do—and do not—show

Nestlé’s figures establish that the company continued to grow across the reported Food and Snacks, retail and out-of-home measures during the first half of 2026. They also establish that the company said the infant-formula recall continued to affect consumer demand.

They do not establish that the recall caused a particular percentage of the company’s revenue or profit result. Nestlé did not quantify the recall’s separate financial effect in the supplied materials, so its contribution cannot be calculated from the reported growth rates or net profit.

The next known development in the packet is the July 23 half-year results release itself. No further deadline, product-clearance date or timetable for the recall’s resolution is provided. The continuing question for consumers and investors is whether demand in affected infant-formula markets returns to normal and how the recall-related effects appear in later company reporting.

The FDA posted the company’s recall announcement on July 9, 2026, as a public-service safety notice. The recalled formula was distributed nationally through Target stores, Target.com and Nara.com.

What the recall covers

The recall covers all lots of Nara Organics powdered infant formula. The stated distribution period ran from July 2025 through June 2026, meaning the affected products may have been available through both retail stores and online purchasing channels over that period.

The FDA’s notice identifies Target and Nara.com as distribution channels. It does not say that all infant formula sold by Target was recalled. The action applies to the Nara Organics powdered infant formula identified in the announcement.

Because the recall is nationwide, the issue is not limited to a particular state or store location. Families who obtained the product through Target stores, Target.com or Nara.com may need to determine whether they have recalled formula and arrange a safe alternative. Retailers and clinicians may also need to help identify affected products and support alternative nutrition arrangements.

What is not yet specified

The available FDA record describes the reason for the action as a possible health risk, but it does not specify the suspected contaminant or explain the precise illness risk. It also does not provide, in the supplied record, lot numbers or details about reported illnesses.

The record does not establish whether every package size was included or whether the recall affected only particular formulations. Those details matter to caregivers trying to determine whether a product in their home is covered, but they are not provided in the approved information available for this report.

The recall should therefore not be described as a confirmed contamination finding. The FDA record supplied for this report supports the existence and scope of the recall and the company’s stated reason—a possible health risk—but does not establish contamination, illnesses or injuries.

Why the notice matters

Infant formula is a critical nutrition product. A nationwide recall can create an immediate identification and access problem for families who depend on formula, particularly when the available notice does not include all of the product-level details needed to distinguish affected items.

The practical impact extends beyond consumers. Retailers may need to identify products connected to the recall, while clinicians and caregivers may need to coordinate safe alternatives. The FDA’s public posting makes the announcement available nationally and places the recall within the agency’s broader system for food, drug and product safety information.

The FDA says its safety-information database distinguishes recalls, public-health alerts and other safety information. The agency also explains that company recall announcements are posted as a public service. In this case, the posted notice records a company recall rather than a separate finding in the supplied material that contamination or illness has been confirmed.

What happens next

The known next step is the public distribution of the recall announcement through the FDA’s safety-information system. The supplied record does not provide a consumer response deadline, a replacement deadline, additional company instructions, a suspected contaminant, lot numbers or a separate report of illnesses.

Until those details are available in the approved record, the central verified facts remain the scope of the action—all lots of Nara Organics powdered infant formula—the possible health-risk rationale, and the national distribution through Target stores, Target.com and Nara.com during the July 2025-to-June 2026 period.